Cannabis Science Inc (CBIS) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
19800 MACARTHUR BLVD., SUITE #300 IRVINE, CA 92612 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2017 MRQ | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 333 | 62 | 10 | 1 | 24 | |||
| Cash and cash equivalent | 333 | 62 | 10 | 1 | 24 | |||
| Receivables | 36 | 39 | 77 | 140 | ||||
| Inventory, net of allowances, customer advances and progress billings | 103 | 19 | ✕ | ✕ | ||||
| Inventory | 103 | 19 | ||||||
| Other undisclosed current assets | 232 | 194 | 156 | 225 | 550 | |||
| Total current assets: | 704 | 315 | 166 | 303 | 713 | |||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 2 | 16 | ||||||
| Long-term investments and receivables | 273 | 129 | 244 | 225 | 525 | |||
| Long-term investments | 273 | 129 | 244 | 225 | 525 | |||
| Intangible assets, net (including goodwill) | 172 | 386 | 273 | 378 | ||||
| Goodwill | 171 | 66 | 44 | |||||
| Intangible assets, net (excluding goodwill) | 172 | 215 | 207 | 334 | ||||
| Prepaid expense | 4,449 | 3,553 | ✕ | |||||
| Other undisclosed noncurrent assets | 48 | 972 | (3,477) | (3,778) | (525) | |||
| Total noncurrent assets: | 492 | 1,486 | 1,215 | 274 | 394 | |||
| TOTAL ASSETS: | 1,196 | 1,801 | 1,382 | 577 | 1,107 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 1,589 | 2,595 | 1,870 | 1,503 | 1,473 | |||
| Employee-related liabilities | 300 | 300 | ||||||
| Accounts payable | 405 | 680 | 153 | 166 | 158 | |||
| Accrued liabilities | 884 | 1,615 | 1,717 | 1,337 | 1,314 | |||
| Due to related parties | 538 | 414 | 204 | 191 | 197 | |||
| Other undisclosed current liabilities | 1,507 | 1,407 | 1,881 | 1,607 | ||||
| Total current liabilities: | 3,634 | 4,416 | 3,955 | 1,694 | 3,276 | |||
| Noncurrent Liabilities | ||||||||
| Other undisclosed liabilities | 2,402 | |||||||
| Total liabilities: | 3,634 | 4,416 | 3,955 | 4,096 | 3,276 | |||
| Equity | ||||||||
| Equity, attributable to parent, including: | (1,846) | (2,101) | (2,573) | (3,519) | (2,169) | |||
| Preferred stock | 1 | 1 | 1 | 1 | 1 | |||
| Common stock | 2,350 | 1,582 | 1,032 | 771 | 664 | |||
| Common stock, share subscribed but unissued, subscriptions receivable | (655) | (382) | ||||||
| Additional paid in capital | 136,103 | 127,942 | 110,256 | 91,771 | 86,605 | |||
| Deferred compensation equity | (1,706) | (3,209) | ||||||
| Retained earnings (accumulated deficit) | (137,929) | (128,017) | (109,393) | (92,509) | 86,574 | |||
| Other undisclosed equity, attributable to parent | (11) | (18) | (4,470) | (3,553) | (176,013) | |||
| Equity, attributable to noncontrolling interest | (592) | (513) | ||||||
| Total equity: | (2,438) | (2,614) | (2,573) | (3,519) | (2,169) | |||
| TOTAL LIABILITIES AND EQUITY: | 1,196 | 1,801 | 1,382 | 577 | 1,107 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 9 | 44 | 1 | 345 | 37 | ||
| Revenue, net | 83 | 37 | |||||
| Financial services revenue | 262 | ||||||
| Cost of revenue (Cost of Product and Service Sold) | (4) | (7,252) | (3,663) | (1,183) | (50) | ||
| Gross profit: | 5 | (7,208) | (3,662) | (838) | (14) | ||
| Operating expenses | (8,525) | (19,063) | (15,887) | (3,447) | (16,669) | ||
| Other undisclosed operating income | 7,252 | 3,663 | 920 | 50 | |||
| Operating loss: | (8,520) | (19,019) | (15,886) | (3,365) | (16,633) | ||
| Nonoperating expense | (1,471) | (119) | (998) | ||||
| Investment income, nonoperating | (972) | (90) | |||||
| Interest and debt expense | (589) | (5,625) | (5,358) | (2,307) | (4) | ||
| Loss from continuing operations before equity method investments, income taxes: | (10,579) | (24,762) | (22,242) | (5,672) | (16,636) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (263) | 600 | |||||
| Loss from continuing operations: | (10,579) | (24,762) | (22,242) | (5,934) | (16,037) | ||
| Loss before gain (loss) on sale of properties: | (10,579) | (24,762) | (22,242) | (5,934) | (16,037) | ||
| Net loss: | (10,579) | (24,762) | (22,242) | (5,934) | (16,037) | ||
| Net income attributable to noncontrolling interest | 78 | 513 | |||||
| Other undisclosed net income (loss) attributable to parent | 510 | 5,112 | 5,358 | (1) | |||
| Net loss attributable to parent: | (9,990) | (19,137) | (16,885) | (5,934) | (16,038) | ||
| Other undisclosed net income available to common stockholders, basic | 78 | 513 | |||||
| Net loss available to common stockholders, diluted: | (9,912) | (18,624) | (16,885) | (5,934) | (16,038) | ||
Comprehensive Income ($ in thousands)
| 9/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (10,579) | (24,762) | (22,242) | (5,934) | (16,037) | ||
| Other comprehensive income (loss) | (8) | (3) | 21 | ||||
| Comprehensive loss: | (10,587) | (24,765) | (22,221) | (5,934) | (16,037) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 78 | 513 | |||||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 604 | 5,630 | 5,316 | ||||
| Comprehensive loss, net of tax, attributable to parent: | (9,904) | (18,621) | (16,906) | (5,934) | (16,037) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.